Showing results (181-190 of 221) with videos related to

Sort By:
Pageof 23
Plos One|October 13, 2021
Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort dataKazuto Nakae, Sho Masui, Atsushi Yonezawa, et al.
Plos One|August 5, 2021
Influence of dietary habits on depression among patients with rheumatoid arthritis: A cross-sectional study using KURAMA cohort databaseHiroto Minamino, Masao Katsushima, Motomu Hashimoto, et al.
Modern Rheumatology|August 13, 2022
Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Clinical Rheumatology|April 1, 2026
Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohortYuki Etani, Yasutaka Okita, Kohei Tsujimoto, et al.
Scientific Reports|January 8, 2022
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Rheumatology International|March 10, 2022
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort studyYoichi Nakayama, Ryu Watanabe, Kosaku Murakami, et al.
Science Immunology|August 15, 2025
Stem-like and effector peripheral helper T cells comprise distinct subsets in rheumatoid arthritisYuki Masuo, Akinori Murakami, Rinko Akamine, et al.
Science Immunology|August 1, 2025
Human CD4<sup>+</sup> T cells regulate peripheral immune responses in rheumatoid arthritis via insulin-like growth factor-like family member 2Akinori Murakami, Rinko Akamine, Shiro Tanaka, et al.
Rheumatology (Oxford, England)|March 20, 2025
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER CohortKohei Tsujimoto, Kosuke Ebina, Satomi Okamura, et al.
Clinical and Experimental Medicine|May 10, 2024
Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort studyYoichi Nakayama, Akira Onishi, Wataru Yamamoto, et al.
Pageof 23